There is more good news about the HPV vaccine – since being introduced in the UK in 2008, the cervical cancer rate has dropped by 90% according to a recently published peer-reviewed article. Cervical cancer, which kills over 300,000 women a year across the world, is close to being eliminated in countries that recommend the HPV vaccine for women and men.
The HPV vaccine used to be the most hated by anti-vaccine zealots, being surpassed by the COVID-19 vaccine these days, but it is remarkably safe and effective. There are so few ways to prevent cancer, and yet this is one of the best tools that we have in cancer prevention.
Let’s take a look at this new paper, just so we can pile onto the narrative about the overwhelming effectiveness of this vaccine. Continue reading “HPV vaccine has decreased cervical cancer rates in England by 90%”
I have written nearly 200 articles on the HPV vaccine, many on Gardasil vaccine effectiveness, one of the most important issues about this important cancer-preventing vaccine. But that’s so much data, so I wanted to publish one article that reviewed the largest and best peer-reviewed articles that support the claims of Gardasil vaccine effectiveness.
My goal is to make this article your “go-to” source for the best and clearest evidence that the HPV vaccine not only prevents HPV infections but it also significantly decreases cancer risks. Continue reading “Gardasil vaccine effectiveness – prevents HPV and reduces cancer risk”
I know that COVID-19 vaccines are our focus these days, but there is great news about cervical cancer rates in the UK in the decade since the HPV vaccine was first launched in 2008. Cervical pre-cancer incidence is down 88% since the UK’s devolved governments launched a school immunization program in 2008 to vaccinate all girls aged 12-13. They also launched a three-year catch-up program for girls aged 14-18.
These results are amazing and provide further evidence of the effectiveness of this vaccine in reducing cervical cancer rates.
mAs I always do, I will inform readers about HPV and HPV vaccines, then review the article that provides us with these results. Continue reading “Cervical cancer rates down 88% in decade since HPV vaccine launched”
The nearly indisputable evidence of the safety and effectiveness of the HPV vaccine is now supported by powerful evidence that the risk of cervical cancer is greatly reduced by the vaccine. We knew that the vaccine prevented many of the HPV types that were linked to cervical cancer, but it took time for us to observe a concomitant decrease in cases of cervical cancer.
Now, we have that evidence.
Let’s take a look at that study, which I know our favorite anti-vaxxers will dismiss, but maybe it will convince one parent to protect their children from future cases of cervical cancer. Continue reading “HPV vaccine reduces the risk of cervical cancer – another powerful study”
Emma Mhic Mhathúna was a 37-year-old Irish mother of five who died on 7 October 2018 from cervical cancer – an easily diagnosed and treated cancer if discovered early. She died because of a cervical smear scandal in Ireland that led her to receive a false negative on her two pap smear tests in 2016 as a part of the CervicalCheck program run by Ireland’s Health Service Executive (HSE), which manages Ireland’s healthcare.
As a result of this cervical smear scandal, Ms. Mhathúna sued the HSE and the US clinical laboratory, Quest Diagnostics, which performed the tests. She settled in court for €7.5 million from HSE and Quest. Another US-based clinical laboratory, Clinical Pathology Laboratories (CPL) of Austin, TX, was involved in a similar lawsuit from another Irish woman, Vicky Phelan, who also received a false negative – they settled for €2.5 million.
Ms. Mhathúna’s death was both tragic and a cautionary tale about relying upon the results of this test. Continue reading “Cervical smear scandal – why the HPV vaccine is the best choice”
Although I have no poll numbers sitting in front of me, and certainly no scientific peer-reviewed research, I just have a feeling that if you scratch the surface of an anti-vaccine activist, you will find that if they could hate one vaccine, it would be Gardasil. And one of the arguments will be all about Gardasil effectiveness – they claim it doesn’t actually prevent cancer.
When you couple their false claims about the dangers of the vaccine with the claims about the lack of Gardasil effectiveness, you’d probably agree with the anti-vaccine crowd. Despite these false claims, HPV vaccine uptake has slowly grown in the US and other countries.
I’ve written nearly 200 articles about the HPV cancer-preventing vaccine, but most of those are focused on debunking myths and confirming the safety of the vaccine. I’m going to focus on a quick primer about Gardasil effectiveness in preventing cancer. Stay tuned for some interesting science. Continue reading “Gardasil effectiveness – yes, HPV vaccine does protect you against cancer”
One of the misinformed tropes of the anti-vaccine world is that there is no evidence that the human papillomavirus (HPV) vaccine actually reduces cancer rates. Given that the vaccine was only introduced in the last 10 years, it would take time for researchers to study this issue. But now, we have more evidence that the cervical cancer rate declined after the introduction of the HPV vaccine in the USA.
We have robust evidence that the HPV vaccine actually stops HPV infections, which are linked to several types of cancer. Over the past few years, a number of published articles have provided us with powerful evidence that the HPV vaccine is significantly reducing the cervical cancer rate.
Although there is a myth that the HPV vaccine is just to prevent cervical cancer, I expect, over the next few years, there will be new research that shows reductions in other cancers, in both women and men, as a result of the introduction of the vaccine. Moreover, the effect of the vaccine on males may take longer since the vaccine was recommended for males only a few years after it was introduced.
This year, a solid systematic review, the most powerful research in the hierarchy of biomedical science, along with other studies, have been published that provide strong evidence that the HPV vaccine reduces the cervical cancer rate. Now we have a new study to add to the body of science supporting the effectiveness in preventing cancers of the HPV vaccine. Continue reading “Cervical cancer rate declines after introduction of HPV vaccine – new evidence”
The first cancer prevention vaccine was administered in Australia exactly 10 years ago. Since that day, the HPV cancer prevention vaccine as been sold in 130 countries across the world. As a result, HPV vaccine effectiveness has been so high, that the rate of cervical pre-cancerous lesions has been cut in half.
This should be celebrated. As I’ve said at least a few times, the ways to reduce your actual cancer risk is limited. And it does not include drinking a kale-blueberry shake every morning. The real ways to reduce your risk of cancer can be as easy as staying out of the sun to stopping smoking. But the HPV vaccine is one of the most critical tools in the “war on cancer.”
Let’s take a look at the HPV cancer prevention vaccine and how effective it actually has been on cervical cancer. Continue reading “HPV vaccine effectiveness – cervical cancer rate halved in 10 years”
If you overlook the plain ignorance of junk medicine pushers on the internet, it’s clear that there’s only a few things that you can do to lower your risk of cancer. Quitting tobacco is probably the biggest one. But right up there is the fact that the HPV vaccine lowers cancer risk – and as a consequence, lowers health care costs generally.
Despite it’s clear benefit to human health, the HPV cancer preventing vaccine, also known as Gardasil, is under utilized in the USA. There seems to be a lot of reasons why HPV vaccine uptake is low, but the evidence is clear that it is safe, it reduces cancer risk, and it lowers the costs of healthcare.
So, let’s take a look at some of the data.
Continue reading “HPV vaccine lowers cancer risk and healthcare costs”